PTC
ATRS

Petrus Trust Company’s Antares Pharma, Inc. ATRS Stock Holding History

Petrus Trust Company’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,437
Closed -$67K – 165
2022
Q1 		$67K Buy
+16,437
New +$59.6K 0.01% 66

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Petrus Trust Company's ATRS Position: Q2 2022 in Review

Petrus Trust Company sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 16,437 shares — an estimated $67K sold.

Petrus Trust Company first reported a position in ATRS in Q1 2022 and held it in 1 quarter. The position peaked at $67K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Petrus Trust Company reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Petrus Trust Company sold 16,437 Antares Pharma, Inc. shares in Q2 2022, an estimated $67K.
  • Petrus Trust Company first reported a position in Antares Pharma, Inc. in Q1 2022 and held it in 1 quarter.
  • Petrus Trust Company's Antares Pharma, Inc. position peaked at $67K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Petrus Trust Company's 13F filing for Q2 2022, filed 15 Aug 2022.